Industries > Pharma > Cell-Based Assays Market Report to 2030

Cell-Based Assays Market Report to 2030

Forecasts by Product (Instruments (Microplates, Microplate Reader, Liquid Handling System), Consumables (Reagents, Assay Kits, Cell Lines, Probes & Labels), Software, Services), by Application (Drug Discovery, Basic Research, ADME Studies, Predictive Technology), by Technology (Automated Liquid Handling, Flow Cytometry, Label-Free Detection, High-Throughput Screening), by End-User (Pharma & Biotech Companies, Academic Institutes, CROs) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Cell-Based Assays Companies AND COVID-19 Recovery Scenarios

PUBLISHED: 04 March 2021
PAGES: 454
PRODUCT CODE: PHA1078

Clear
WOOCS 2.2.1

The cell-based assay market is estimated to grow at a CAGR of xx% over the forecast period. The rising preference for cell-based assays in drug discovery, increasing funding for cell-based research, and growth in the number of drug discovery activities are the key factors supporting the growth of the market.

Evolving economies, growing pandemic risk and communicable diseases and application of cell-based assay in oncology research area is assured to provide profitable growth opportunities to the players in this market. For instance, phenotypic screening approaches are again rising in popularity in the drug discovery business, there is a need for robust and efficient assays that enable the study of the nervous system. Phenotypic assays can be highly predictive for infectious and metabolic diseases, however, for more complex disease areas such as the nervous system and cancer, more effort needs to be placed in designing sufficient and accurate models and assays. Cell-based assays are now emerging, such as for pain sensitisation and also in the screening of clinical compounds to treat Alzheimer’s disease. It is hoped that the further development of these cell-based assays will open the door for phenotypic screening approaches in nervous system and pain drug discovery thus, bolstering the growth of the market.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

The report provides a profound understanding into the global cell-based assay market covering all its essential aspects. This ranges from macro overview of the market to micro details of the industry performance, recent trends, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc. This report is a must-read for entrepreneurs, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the cell-based assay industry in any manner.

As the coronavirus disease (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the purchase behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.

To access the data contained in this document please email contactus@visiongain.com

In this brand-new 454-page report you will receive 283 charts– all unavailable elsewhere. The 454-page Visiongain report provides clear detailed insight into the cell-based assay market. Discover the key trends and development in the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

CTA

Report Scope

• Global cell-based assay market forecasts from 2020-2030

• This report also breaks down the revenue forecast to 2030 for the global cell-based assay market by product, technology, application and end-user:

By Product
• Consumables
• Instruments
• Software & Services

By Technology
• Automated Handling
• Flow Cytometry
• Label-Free Detection
• High-Throughput Screening

By Application
• Drug Discovery
• Basic Research
• ADME Studies
• Predictive Technology

By End-User
• Pharma & Biotech Companies
• Academic Institutes
• CROs

This report discusses the market trends and developments of each submarket.

Cell-Based Assays Market Report to 2030
Need industry data? Please contact us today.

Our study discusses the selected leading companies that are the major players in the cell-based assay market:
• DiscoverX Corporation (Eurofins DiscoverX)
• Thermo Fisher Scientific
• Cell Assay Innovations, Inc.
• InSphero AG
• QGel SA.
• Becton, Dickinson and Company
• Promega Corporation
• BioVision, Inc.
• Marin Biologic Laboratories
• Molecular Devices, LLC. (Danaher Corporation)
• Porsolt
• CYTOO SA
• Pharmaceutical Product Development, LLC.
• ProQinase GmbH
• Charles River Laboratories International, Inc.
• BioAgilytix Labs
• SGS Group
• Perkin Elmer Inc.
• General Electric Company (GE Healthcare)
• F. Hoffmann-La Roche AG
• Merck KGaA
• Corning Inc.
• Bio-Rad Laboratories

Visiongain’s study is intended for anyone requiring commercial analyses for the global cell-based assay market. You find data, trends and predictions.

To access the data contained in this document please email contactus@visiongain.com

Buy our report today Cell-Based Assays Market Report to 2030: Forecasts by Product (Instruments (Microplates, Microplate Reader, Liquid Handling System), Consumables (Reagents, Assay Kits, Cell Lines, Probes & Labels), Software, Services), by Application (Drug Discovery, Basic Research, ADME Studies, Predictive Technology), by Technology (Automated Liquid Handling, Flow Cytometry, Label-Free Detection, High-Throughput Screening), by End-User (Pharma & Biotech Companies, Academic Institutes, CROs) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Cell-Based Assays Companies AND COVID-19 Recovery Scenarios. Avoid missing out by staying informed – order our report now.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com

Download sample pages

Complete the form below to download your free sample pages for Cell-Based Assays Market Report to 2030


Download sample pages

Complete the form below to download your free sample pages for Cell-Based Assays Market Report to 2030


Latest Pharma news

Visiongain Publishes Clinical Trial Supplies Market Report 2021-2031

Deviating from protocols raises the danger of missing or delaying data collection from current investigations. This highlights the growing importance of digital medicine, which is being aided by advancements in cloud, mobile, and IoT technology.

11 October 2021

READ

Visiongain Publishes Drug Discovery Informatics Market Report 2021-2031

High performance HPC and supercomputing technology have evolved substantially in China in the last decades, leading to extraordinary accomplishments. HPC-based and combined pharmaceutical chemical and computational biology computational discovery and design has become a significant technique in drug research and development and is sponsored financially by the Chinese government.

07 October 2021

READ

Visiongain Publishes Pharma Wholesale and Distribution Market Report 2021-2031

Many health-care organizations are seeing organic growth at levels that their supply networks were never designed to handle. Others are frantically attempting to integrate diverse technology and procedures as part of a consolidation effort.

06 October 2021

READ

Visiongain Publishes Meningococcal Vaccines Market Report 2021-2031

Rise in prevalence of meningitis, increasing initiatives by government and regulatory authorities coupled strong funding support from non-profit organizations is expected to drive the global meningococcal vaccines market

05 October 2021

READ

Categories